The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112893865 11289386 5 F 2015 20160819 20150721 20160826 EXP CA-UCBSA-2015023071 UCB 0.00 F Y 0.00000 20160826 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112893865 11289386 1 PS Certolizumab pegol CERTOLIZUMAB PEGOL 1 Subcutaneous 400 MG, EV 2 WEEKS(QOW) Y U 120320 125160 400 MG QOW
112893865 11289386 2 SS Certolizumab pegol CERTOLIZUMAB PEGOL 1 Subcutaneous 200 MG, EV 2 WEEKS(QOW) Y U 125160 200 MG QOW
112893865 11289386 3 SS Certolizumab pegol CERTOLIZUMAB PEGOL 1 Subcutaneous 200 MG, EV 2 WEEKS(QOW) Y U 125160 200 MG QOW
112893865 11289386 4 SS METHOTREXATE. METHOTREXATE 1 UNK U 0
112893865 11289386 5 SS METHOTREXATE. METHOTREXATE 1 20 MG, WEEKLY (QW) U 0 20 MG /wk
112893865 11289386 6 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 200 MG, 2X/DAY (BID) U 0 200 MG BID
112893865 11289386 7 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 150 MG, 2X/DAY (BID) U 0 150 MG BID
112893865 11289386 8 C FOLIC ACID. FOLIC ACID 1 1 MG, ONCE DAILY (QD) U 0 1 MG QD
112893865 11289386 9 C CELEBREX CELECOXIB 1 200 MG, 2X/DAY (BID) U 0 200 MG BID
112893865 11289386 10 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 UNK, 2X/DAY (BID) U 0 BID
112893865 11289386 11 C FLEXERIL CYCLOBENZAPRINE HYDROCHLORIDE 1 AT BED TIME,PRN U 0
112893865 11289386 12 C NUCYNTA TAPENTADOL HYDROCHLORIDE 1 50 MG, 3X/DAY (TID) U 0 50 MG TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112893865 11289386 1 Rheumatoid arthritis
112893865 11289386 4 Product used for unknown indication
112893865 11289386 6 Product used for unknown indication
112893865 11289386 7 Product used for unknown indication
112893865 11289386 8 Product used for unknown indication
112893865 11289386 9 Product used for unknown indication
112893865 11289386 10 Product used for unknown indication
112893865 11289386 11 Product used for unknown indication
112893865 11289386 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
112893865 11289386 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
112893865 11289386 Arthralgia
112893865 11289386 Asthenia
112893865 11289386 Cough
112893865 11289386 Gait disturbance
112893865 11289386 Nasopharyngitis
112893865 11289386 Oral herpes
112893865 11289386 Oropharyngeal pain
112893865 11289386 Pain
112893865 11289386 Pharyngitis
112893865 11289386 Pneumonia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112893865 11289386 1 20150422 20150520 0
112893865 11289386 2 20150603 201507 0
112893865 11289386 3 20150804 201510 0
112893865 11289386 5 20151013 0
112893865 11289386 6 20151013 0
112893865 11289386 7 20151013 0
112893865 11289386 8 20151013 0
112893865 11289386 9 20151013 0
112893865 11289386 10 20151013 0
112893865 11289386 11 20151013 0
112893865 11289386 12 20151013 0